Bright Minds Biosciences (DRUG) Q2 2026 Earnings — Beat Estimates

Screener

Reported August 17, 2026 · Before market open

EPS-$0.17Beat by $1.05

EPS estimate-$1.22

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q2 2026-$0.17Beat by $1.05

Q1 2026-$0.80Beat by $0.37 Q4 2025-$0.70Beat by $0.28 Q3 2025-$0.41Beat by $0.15 Q1 2025-$0.53Beat by $0.06 Q4 2024$0.01Beat by $0.24

FAQ

When did Bright Minds Biosciences report Q2 2026 earnings?: Bright Minds Biosciences (DRUG) reported Q2 2026 earnings on August 17, 2026 before market open.
What were Bright Minds Biosciences's Q2 2026 revenue and EPS?: Bright Minds Biosciences reported eps of $-0.17 for Q2 2026.
Did Bright Minds Biosciences beat estimates in Q2 2026?: EPS beat the consensus estimate of $-1.22 by $1.05.

Ask the moment Bright Minds Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk